VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Iza-bren (BL-B01D1) + Serplulimab Demonstrates Breakthrough Efficacy as First-Line Therapy for Extensive-Stage Small Cell Lung Cancer
Iza-bren (BL-B01D1) + Serplulimab Demonstrates Breakthrough Efficacy as First-Line Therapy for Extensive-Stage Small Cell Lung Cancer
May 25, 2026 00:00 CST Updated 01:41
Share: